Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Cardiol. Aug 26, 2012; 4(8): 256-259
Published online Aug 26, 2012. doi: 10.4330/wjc.v4.i8.256
Table 1 Clinical data before and after eicosapentaenoic acid administration (n = 19)
VariablesPre-administrationAfter-administrationP value
Systemic hypertension17 (89%)17 (89%)NS
Dyslipidemia14 (74%)14 (74%)NS
Body mass index (kg/m2)23.9 ± 2.323.9 ± 2.5NS
Systolic BP (mmHg)131 ± 16130 ± 13NS
Diastolic BP (mmHg)83 ± 980 ± 7NS
Triglyceride (mg/dL)107 ± 5299 ± 24NS
LDL cholesterol (mg/dL)114 ± 29108 ± 28NS
EPA (%)3.0 ± 1.18.5 ± 2.9< 0.001